Virology All Topics
Virology All Topics
Virology-ALL- Topics
a. Feca – oralNAKED
o Respiratory syncytial virus 3. Serologic procedures to detect a vise in Trypticase Soy Broth or Buffer Normal
o Parainfluenza virus antibody titer or the presence of IgM. Saline Solution:for avoiding drying of
4. Detection of viral antigen in blood or specimen
Rhabdoviridae body fluids.
o Rabies virus 5. Detection of viral nucleic acid in blood Have gelatin, albumin and serum: for
or the patient’s cells. protection of less viable virus
Filoviridae
o Ebola virus Specimen Collection, Handling and Transport Has antibiotics and antifungal: to inhibit
o Marburg virus Aseptically collection the growth of bacteria and fungi
Delayed: 1 – 6oC less than 24 hours
Coronaviridae Long storage: freezer at – IDENTIFICATION OF THE VIRUS IN CELL
o Corona virus (SARS) 70oC(cryoprecipitate) CULTURE
Collect by Dacron or Rayon
Arenaviridae Calcium alginate – type of swab that is Methods of Viral Isolation
o Lymphocytic not allowed to be used because it may A. Cell Culture
Choriomeningitis damage or inactivate the virus B. Animal Inoculation
virus Specimen that are aspirated during C. Embryonated egg Inoculation
o Lassa Fever virus collected for cell culture and does not
need transport medium: A. Cell Culture
o Blood Gold standard (in culturable virus)
Bunyaviridae
o CSF Presumptive test
o California encephalitis virus
o Lacrosse virus o Pleural fluid
o Hantavirus o Synovial fluid
o Pericardial fluid Categories of Preparation:
Deltaviridae o Urine
o Bone marrow aspirate 1. Primary Cell Cuture
o Hepatitis D virus
derived from an animal cell
Transport Medium Rabbit Kidney (RK)or Primary
Viral Transport Medium except for Monkey Kidney (PMK)
LESSON 2: LABORATORY DIAGNOSIS,
TREATMENT AND PREVENTION OF VIRAL blood, urine and other body fluids.
Specimens that need transport medium a. A tissue is treated with enzyme to
INFECTIONS
which is collected only in swabs or separate the cells (treated with
respiratory specimen trypsin).
Laboratory Diagnosis of Viral Infection
o Throat b. Cells are suspended in culture
1. Identification of the virus in cell culture.
o Nasopharyngeal medium.
2. Microscopic identification directly in the
o Vaginal c. Normal cells or primary cells grow
specimen. in a monolayer across the glass or
plastic container. Transformed cells
5. Patients with infectious mononucleosis 3. Can be quantitative specialized training B) Inhibition of nucleic acid synthesis by
and those with connective tissue 4. Can detect viruses and facilities viral DNA and RNA polymerase
unculturable by cell
diseases such as SLE may react non- 5. Ability to detect o Most of the drugs for antiviral
specifically giving a false positive result multiple viruses o Protease inhibitors
6. Patients have given blood or blood simultaneously
products may give a false positive result 1. Acyclovir 14. Stavudine
due to the transfer of Ab. 2. Ganciclovir 15. Lamivudine
LESSON 3: TREATMENT FOR VIRAL INFECTION 3. Valacyclovir 16. Abacavir
DETECTION OF VIRAL ANTIGEN IN BLOOD OR (ANTIVIRAL DRUG) 4. Valganciclovir 17. Nevirapine
BODY FLUIDS 5. Penciclovir 18. Delavirdine
Potential Sites for Antiviral Chemotherapy 6. Famciclovir 19. Efavirenz
Respiratory syncytial virus 7. Cidofovir 20. Ribavirin
Influenza A and B virus Inhibition of early events (entry or
Nasopharyngeal Aspirate
8. Vidarabine 21. Adenofuvir
Parainfluenza virus
uncoating of a virus) 9. Iododeoxyuridine 22. Erecavir
Adenovirus
Inhibition of nucleic acid synthesis by viral 10. Trifluridine 23. Telbivudine
Rotavirus DNA and RNA polymerase 11. Foscarnet 24. Emtricitabine
Feces Adenoviruses Inhibition of integrase that integrates HIV 12. Zidovudine 25. Tenofovir
Herpes simplex virus DNA into cellular DNA 13. Didanosine
Skin Varicella-zoster virus Inhibits cleavage of precursor
Blood Cytomegalovirus polypeptides
Inhibits protein synthesis directed by viral C) Inhibition of integrase that integrates
NUCLEIC ACID-BASED DETECTION IN CLINICAL mRNA HIV DNA into cellular DNA
SAMPLES Inhibits release of virus
1. Raltegravir
Gold standard (in non-culturable A) Inhibition of early events (entry or
virus) uncoating of a virus) D) Inhibits cleavage of precursor
polypeptides
1. PCR 1. Docosanal – blocks the HSV entry
2. Nucleic acid sequence based into the cell 1. Saquinavir 6. Darunavir
amplification 2. Enfuvirtide – blocks the HIV entry 2. Indinavir 7. Atazanavir
3. Flow cytometry into the cell 3. Ritonavir 8. Lopinavir
4. Nucleic acid hybridization 3. Maraviroc – blocks the HIV entry 4. Nelfinavir 9. Tipranavir
into the cell 5. Amprenavir
ADVANTAGES DISADVANTAGES 4. Amantadine – blocs the Influenza A
1. Quicker turned – 1. Detection of both virus uncoating
around times activated and 5. Rimantadine – blocs the Influenza A E) Inhibits protein synthesis directed by
2. Better sensitivity inactivated virus
virus uncoating viral mRNA
than cell culture and 2. Increased cost
DFA 3. Need for
via the original route of the virus.(Ex. 2. Adjuvant needed (Substance that Rotavirus
Rotavirus – oral) enhances immune response) Herpes simplex virus
type 2
* FDA (Food and Drug Administration) – 3. Need several doses ECHO virus
regulatory body 4. Shorter lasting immunity Congenital and Neonatal
Parvovirus B19
Diseases
vaccines Varicella-zoster virus
* Storage of live vaccine: refrigerated (dies at HIV
Hepatitis viruses
room Maternal Antibody
temperature) - Antibody present from the mother
* Virulence – degree of causing disease passed to the baby List of Viral Syndrome and Common Viral
- 1 year is given to clear out the Pathogens
LIVE (Attenuated) VACCINE maternal Ab (Adults)
Infectious Epstein-Barr virus 1. Infectious Agents (e.g. virus, bacteria, o Naked (resistant to ether, acid, heat
mononucleosis Cytomegalovirus parasite) at 60oC for 1 hour), icosahedral,
Coxsackie viruses
Herpes simplex virus type
2. Alcohol linear, ss RNA
2 3. Drugs (Drug – induced Hepatitis) o 28 nm
Lymphocytic
Meningitis
Choriomeningitis Forms of Viral Hepatitis Transmission: Fecal-oral route
virus
ECHO virus
Acute
Mumps virus Fulminant Acute Incubation Period:
Herpes simplex virus type ̵̵ Leads to coma because of the o 15 - 45 days
1 accumulation of ammonia. o Average of 28 days
Togaviridae
̵̵ Leads to liver failure.
Bunyaviridae
Encephalitis Subclinical: No signs and symptoms. Treatment: Supportive Care
Flaviviridae
Rabies virus Chronic
Enteroviruses Prevention/Vaccine:
Measles virus
Clinical Findings of Viral Hepatitis o Inactivated vaccine (Twinrix) 2
Hepatitis Hepatitis A, B, C, D, E, G
Adenovirus
Fever doses with 1 month interval
Hemorrhagic cystitis Anorexia
BK virus o Treatment of water
Herpes simplex virus Nausea
Varicella-zoster virus Vomiting Diagnosis:
Enteroviruses
Jaundice 1. HAV Ag
Measles virus
Cutaneous infection Rubella virus Dark urine 2. IgM anti - HAV
with or without rash Parvovirus B19 Pale feces 3. IgG anti - HAV
Human papillomavirus Elevated transaminase
Smallpox virus
Molloscum contagiosum NOTES:
virus TB: 0.2 1.0 mg/dL • Subclinical
Lassa virus Jaundice: >2 mg/DL • No Chronic Disease
Yellow fever virus
Self – limiting
Hemmorhagic Fever Marburg virus HEPATITIS A VIRUS
Ebola virus
Dengue virus Family: Picornaviridae HEPATITIS B VIRUS
HIV – 1 Genus: Enterovirus/Hepatovirus
Generalized (no specific
HIV -2 Family: Hepadnaviridae
target organ)
HTLV-1 Other names: Genus: Orthohepadnavirus
1. Infectious Hepatitis
2. Enterovirus 72 Other names:
LESSON 5: VIRAL HEPATITIS 3. Short Incubation Hepatitis 1. Serum Hepatitis
2. Dane Particle
3 Possible Causes of Hepatitis Morphology: 3. Long Incubation Hepatitis
4. Australian Hepatitis
Family: Flaviviridae
Morphology: Disease State Healthy Genus: Hepacivirus
o Enveloped, Icosahedral, Circular, ds
Acute Early
Late Acute
Vaccinate
DNA Other name: Non - A Non - B Hepatitis
Resolved
Chronic
Acute
Early
o 42 nm
Morphology:
Transmission: Parenteral, Perinatal, Sexual o Enveloped, Icosahedral, Linear,
HBsAg + + + + + - - ssRNA
Intercourse
HBeAg - + + + - - -
o 45 nm
Anti – - - - + +/- + -
Incubation Period: HBc
o 40 - 180 days Anti - - - - - - + + Transmission: Parenteral, Sexual Intercourse
o Average 60 - 90 days HBs
Anti – - - - - +/- +/- +/- Incubation Period: 30 - 50 days
HBe
Treatment: DNA + + + + + - -
o Supportive Care virus Treatment:
o HB immunoglobulin o Supportive care
o Interferon 2 Categories of Chronic Hepatitis o Interferon
o Lamivudine 1. Chronic Persistent Hepatitis - LFT o Ribuvirin
o Liver Transplant 2. Chronic Active Hepatitis - LFT o Liver Transplant
Prevention/Vaccine:
Vaccine: Inactivated vaccine (3 doses) General Serologic Test for Viral Hepatitis o No vaccine available
1. First Generation
Diagnosis: ̵̵ Ouchterlony agar plate Diagnosis:
1. HBsAg - first marker to appear during
1. Anti – HCV
HBV. 2. Second Generation 2. HCV - RNA
2. HBeAg - next to appear, HIgh infectivity. ̵̵ Counter electrophoresis
3. HBcAg - no serological significance; for (Countercurrent NOTES:
liver biopsy. immunoelectrophoresis) HCV - major cause of liver cirrhosis plus
4. IgM anti - HBc - first antibody to appear
alcoholic hepatitis
5. IgG anti - HBc - lifelong marker HBV 3. Third Generation
infection. ̵̵ RIA, ELISA, Reverse Passive
6. Anti - HBs - last to appear for immunity. Hemagglutination HEPATITIS D VIRUS
7. HBV DNA - using PCR ̵̵ Reverse Passive Latex
Agglutination Family: Deltaviridae
NOTE: Anti - HBc - window period Genus: Deltavirus
Norwalk because first case in 1969, it is a o Hand washing, proper sewage When Ag detection = S protein/ Soluble
place in OHAIO ( there’s an outbreak in a disposal, proper hygiene protein
school)
ECHO VIRUS (+) Current infection
Order: Unassigned
Family: Caliciviridae (Enteric Cytopathic Human Orphan) When Ab detection = HN/ Hemagglutinin
Genus: Norovirus Neuraminidase
Species: Norwalk virus Orphan – because there is no permanent
site of infection; causing different (+) Previous infection
Structure: Naked, Icosahedral , diseases.
with SS (+) polarity, Linear, RNA,
38 nm Order: Picornavirales
Family: Picornaviridae
Transmission: Fecal-oral route Genus: ParECHOvrius
Disease: Viral Gastroenteritis in Structure: Naked, Icosahedral, with VIRAL AGENTS OF PAROTID GLAND
adults SS, Linear, RNA, 28 nm
Where: School, camping MUMPS VIRUS
and cruise ship (often Serotypes: More than 30 Serotypes It is name because of the disease it
places) causes.
Transmission: Fecal-oral route
Clinical Findings: Order: Mononegavirales
o Sudden onset of vomiting Disease: Family: Paramyxovirdidae
and diarrhea o Infantile diarrhea Sub family: Paramyxovirinae
o Low-grade fever (not o Aseptic meningitis Genus: Rubulavirus
over 380C) o Upper Respiratory Tract
o Abdominal cramping Infection Structure: Enveloped, Helical, with
o Febrile illness with or w/o rash SS, Linear, RNA, 150 nm
Lab diagnosis: o Hemorrhagic conjunctivitis
- PCR based test on stool Serotype: 1 serotype
Lab diagnosis: Cell culture
Treatment: Transmission: Respiratory droplets
- No anti-viral drugs Treatment: No anti-viral drugs
available available Disease: Mumps
- Rehydration
Vaccine: NO VACCINE Incubation period: 18-21 days (3
Vaccine: weeks)
o NO VACCINE Note:
A. gag o Transports late mRNA from nucleus to Short flu-like illness occurs 1-6 weeks
o Group Specific Antigen cytoplasm after infection.
o p24, p7, p17 No symptoms at all
o Nucleocapsid matrix protein ACCESSORY GENES: infectivity of a virus Infected person can infect other
people.
B. pol A. nef Most likely false negative result under
o Reverse transcriptase o Negative Replication Factor ELISA.
o p64 o Nef
o Transcribe RNA to DNA o Decreases CD4 proteins and Class I MHC STAGE 2 – ASYMPTOMATIC
proteins on surfaces of infected cell;
o p32 decreasing CD4 and killing CD8 Lasts for an average of 10 years.
o Protease This stage is free from symptoms
o Cleaves precursor polypeptide There may be swollen glands
B. vif The level of HIV in the blood drops to
o p10 o Viral Infectivity Factor very low levels
o Vif HIV Ab are detectable in the blood
o Integrase
o Integrate viral DNA host cell DNA o Enhances infectivity by inhibiting the
action of APOBEC3G (produced by STAGE 3 – SYMPTOMATIC
C. env immune system that we used for
combating the viruses.) The symptoms are mild
o gp120
The immune system detoriates
o DNA Attachment to CD4
C. vpr Emergence of opportunistic infection
o Viral Protein R and cancers
o gp41
o Fusion with host cell o Vpr
o Transports viral core from cytoplasm into STAGE 4 – HIV AIDS
Genus: Orthopoxvirus
Host: Human with single serotype Incubation period: 14-21 days (for
Structure: Enveloped, complex, with Varicella only)
Transmission: DS, Linear, RNA, 250x400 nm
- Respiratory aerosol Clinical Findings: Fever, Malaise,
- Direct contact with skin Transmission: Respiratory aerosol Pruritus rashes
lesions or infected fomites
Disease: Vaccinia
Disease: Small pox FACTORS TO ACTIVATE VIRUSES:
Clinical Findings: Asymptomatic but 1. Stress
Incubation period: 7-14 days may cause mild rash and fever 2. Mechanical Injury
Clinical Findings: 3. Too much exposure to sun
o Fever Lab Diagnosis: Ab titer 4. High fever
o Malaise
o Followed by RASH evolving Vaccine: Live, attenuated vaccine Complications
through stages from: (1) o Encephalitis
Macules, (2)Papules, (3) o Varicella Pneumoniae
Vesicles, (4) Pastules,(5) Crusts VARICELLA ZOSTER VIRUS
in 2 weeks Order: Unassigned Lab Diagnosis:
Family: Herpesviridae - Tzanck smear (Presumptive
Treatment: No anti – viral drugs Genus: Herpesvirus test)
- Viral Culture
Vaccine: Live, Attenuated vaccine Structure: Enveloped, Icosahedral - Ab titer
with DS linear DNA, 100 nm
INCIDENCE OF SMALL POX Treatment:
Host: Human and only 1 serotype - Acyclovir – moderate to severe
YEAR INCIDENCE cases
1960 Small pox is widespread in Africa, Asia and Transmission: Respiratory droplet & - For immune compromised
South America Direct contact with lesions patient:
1967 WHO had vaccine campaign that led to
eradication of smallpox 1. Foscarnet - Acyclovir
1977 Last naturally occurring cause in Somalia Disease: resistant strains of VZV
o Varicella/Chicken pox – 2. Famcyclovir and
primary Valacyclovir – for Zosters
VACCINIA VIRUS o Zoster / Shingles – recurrent Vaccine:
infection 1. Varivax – ages 1-12 years old
Order: unassigned (Varicella)
Family: Poxviridae NOTE: Varicella - most common in children 2. Zostavax – 60 years old and
Sub Family: Chordopoxvirinae Shingles - in adults above (Zoster).
Bunyaviridae
- Califonia encephalitis virus
Transmission:
- Insect bite
- Also transmit Transovarian
Clinical Findings:
o Myalgia
o Viremia
o Non- hemorrhagic rash
o Petechiae
o Fever
o Headache
o Can lead to encephalitis and
hemorrhagic fever
Arthropod vectors
o Mosquitoes
- Japanese
encephalitis,
Dengue, Yellow
fever, St. Louis
encephalitis, EEE,
WEE
o Ticks
- Crimean – Congo
Hemorrhagic Fever
o Sandflies
- Sicilian sandfly fever,
Rift Valley Fever